Quantamental Technologies LLC Biomarin Pharmaceutical Inc Transaction History

Quantamental Technologies LLC

  • $105 Million
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$64.27 - $86.37 $259,457 - $348,675
-4,037 Closed
0 $0
Q3 2019

Nov 08, 2019
BUY
$67.4 - $85.11 $272,093 - $343,589
4,037 New
4,037 $272,000
Q2 2019

Aug 12, 2019
SELL
$80.35 - $93.9 $65,887 - $76,998
-820 Closed
0 $0
Q1 2019

Apr 29, 2019
SELL
$84.2 - $98.62 $61,297 - $71,795
-728 Reduced 47.03%
820 $73,000
Q4 2018

Jan 28, 2019
BUY
$80.14 - $106.07 $124,056 - $164,196
1,548 New
1,548 $132,000

Others Institutions Holding BMRN

# of Institutions
623
Shares Held
181M
Call Options Held
1.73M
Put Options Held
1.73M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email